相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Green tea EGCG plus fish oil omega-3 dietary supplements rescue mitochondrial dysfunctions and are safe in a Down's syndrome child
Rosa Anna Vacca et al.
CLINICAL NUTRITION (2015)
Designer Receptors Enhance Memory in a Mouse Model of Down Syndrome
Ashley M. Fortress et al.
JOURNAL OF NEUROSCIENCE (2015)
Long-term effects of neonatal treatment with fluoxetine on cognitive performance in Ts65Dn mice
Fiorenza Stagni et al.
NEUROBIOLOGY OF DISEASE (2015)
Chronic P7C3 treatment restores hippocampal neurogenesis
Sarah E. Latchney et al.
NEUROSCIENCE LETTERS (2015)
Temporal phases of long-term potentiation (LTP): myth or fact?
Abdul-Karim Abbas et al.
REVIEWS IN THE NEUROSCIENCES (2015)
Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports
Jennita Reefhuis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design
Kari Furu et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports
Jennita Reefhuis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design
Kari Furu et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Protein Dynamics Associated with Failed and Rescued Learning in the Ts65Dn Mouse Model of Down Syndrome
Md Mahiuddin Ahmed et al.
PLOS ONE (2015)
Formoterol, a Long-Acting β2 Adrenergic Agonist, Improves Cognitive Function and Promotes Dendritic Complexity in a Mouse Model of Down Syndrome
Van Dang et al.
BIOLOGICAL PSYCHIATRY (2014)
Prenatal pharmacotherapy rescues brain development in a Down's syndrome mouse model
Sandra Guidi et al.
BRAIN (2014)
Prenatal treatment of Down syndrome: a reality?
Faycal Guedj et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2014)
Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice
Christy M. Kelley et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2014)
Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome
Andrea Corrales et al.
JOURNAL OF PINEAL RESEARCH (2014)
Epigallocatechin-3-gallate, a DYRK1A inhibitor, rescues cognitive deficits in Down syndrome mouse models and in humans
Rafael De la Torre et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2014)
Fluoxetine in adulthood normalizes GABA release and rescues hippocampal synaptic Plasticity and spatial memory in a mouse model of Down Syndrome
Tatjana Begenisic et al.
NEUROBIOLOGY OF DISEASE (2014)
Maternal choline supplementation improves spatial mapping and increases basal forebrain cholinergic neuron number and size in aged Ts65Dn mice
Jessica A. Ash et al.
NEUROBIOLOGY OF DISEASE (2014)
Monoacylglycerol Lipase Inhibitor JZL184 Improves Behavior and Neural Properties in Ts65Dn Mice, a Model of Down Syndrome
Larisa V. Lysenko et al.
PLOS ONE (2014)
Pharmacological approaches to improving cognitive function in Down syndrome: current status and considerations
Katheleen J. Gardiner
DRUG DESIGN DEVELOPMENT AND THERAPY (2014)
New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate
Hae-Suk Kim et al.
REDOX BIOLOGY (2014)
Pregnancy alters choline dynamics: results of a randomized trial using stable isotope methodology in pregnant and nonpregnant women
Jian Yan et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2013)
Early Pharmacotherapy with Fluoxetine Rescues Dendritic Pathology in the Ts65Dn Mouse Model of Down Syndrome
Sandra Guidi et al.
BRAIN PATHOLOGY (2013)
Short-term treatment with the GABAA receptor antagonist pentylenetetrazole produces a sustained pro-cognitive benefit in a mouse model of Down's syndrome
D. Colas et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Prospects for Improving Brain Function in Individuals with Down Syndrome
Alberto C. S. Costa et al.
CNS DRUGS (2013)
Lithium rescues synaptic plasticity and memory in Down syndrome mice
Andrea Contestabile et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Size Does Not Always Matter: Ts65Dn Down Syndrome Mice Show Cerebellum-Dependent Motor Learning Deficits that Cannot Be Rescued by Postnatal SAG Treatment
Nicolas Gutierrez-Castellanos et al.
JOURNAL OF NEUROSCIENCE (2013)
Reducing GABAA α5 Receptor-Mediated Inhibition Rescues Functional and Neuromorphological Deficits in a Mouse Model of Down Syndrome
Carmen Martinez-Cue et al.
JOURNAL OF NEUROSCIENCE (2013)
Long-term oral administration of melatonin improves spatial learning and memory and protects against cholinergic degeneration in middle-aged Ts65Dn mice, a model of Down syndrome
Andrea Corrales et al.
JOURNAL OF PINEAL RESEARCH (2013)
Environmental enrichment rescues DYRK1A activity and hippocampal adult neurogenesis in TgDyrk1A
Meritxell Pons-Espinal et al.
NEUROBIOLOGY OF DISEASE (2013)
Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome
Ramon Velazquez et al.
NEUROBIOLOGY OF DISEASE (2013)
GluN2B Antagonism Affects Interneurons and Leads to Immediate and Persistent Changes in Synaptic Plasticity, Oscillations, and Behavior
Jesse E. Hanson et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Pharmacotherapy with Fluoxetine Restores Functional Connectivity from the Dentate Gyrus to Field CA3 in the Ts65Dn Mouse Model of Down Syndrome
Fiorenza Stagni et al.
PLOS ONE (2013)
Noninvasive prenatal testing creates an opportunity for antenatal treatment of Down syndrome
Faycal Guedj et al.
PRENATAL DIAGNOSIS (2013)
Hedgehog Agonist Therapy Corrects Structural and Cognitive Deficits in a Down Syndrome Mouse Model
Ishita Das et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The effects of maternal depression and maternal selective serotonin reuptake inhibitor exposure on offspring
J. D. A. Olivier et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2013)
Maternal antidepressant use and adverse outcomes: a cohort study of 228,876 pregnancies
Rachel M. Hayes et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2012)
Deficits in Cognition and Synaptic Plasticity in a Mouse Model of Down Syndrome Ameliorated by GABAB Receptor Antagonists
Alexander M. Kleschevnikov et al.
JOURNAL OF NEUROSCIENCE (2012)
Down syndrome: the brain in trisomic mode
Mara Dierssen
NATURE REVIEWS NEUROSCIENCE (2012)
LACK OF BEHAVIORAL AND COGNITIVE EFFECTS OF CHRONIC ETHOSUXIMIDE AND GABAPENTIN TREATMENT IN THE TS65DN MOUSE MODEL OF DOWN SYNDROME
V. Vidal et al.
NEUROSCIENCE (2012)
Prenatal Treatment Prevents Learning Deficit in Down Syndrome Model
Maddalena Incerti et al.
PLOS ONE (2012)
Mouse Models of Down Syndrome as a Tool to Unravel the Causes of Mental Disabilities
Noemi Rueda et al.
NEURAL PLASTICITY (2012)
Adult-Onset Fluoxetine Treatment Does Not Improve Behavioral Impairments and May Have Adverse Effects on the Ts65Dn Mouse Model of Down Syndrome
Markus Heinen et al.
NEURAL PLASTICITY (2012)
Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome
Jason Lockrow et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
Widespread Proliferation Impairment and Hypocellularity in the Cerebellum of Fetuses with Down Syndrome
Sandra Guidi et al.
BRAIN PATHOLOGY (2011)
α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome
Mototada Shichiri et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
APP-dependent up-regulation of Ptch1 underlies proliferation impairment of neural precursors in Down syndrome
Stefania Trazzi et al.
HUMAN MOLECULAR GENETICS (2011)
Rescue of Synaptic Failure and Alleviation of Learning and Memory Impairments in a Trisomic Mouse Model of Down Syndrome
Julie Blanchard et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2011)
Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down Syndrome: Activation of pradrenergic receptor by xamoterol as a potential cognitive enhancer
Mehrdad Faizi et al.
NEUROBIOLOGY OF DISEASE (2011)
Prevention of Learning Deficit in a Down Syndrome Model
Maddalena Incerti et al.
OBSTETRICS AND GYNECOLOGY (2011)
Is it possible to improve neurodevelopmental abnormalities in Down syndrome ?
Renata Bartesaghi et al.
REVIEWS IN THE NEUROSCIENCES (2011)
Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome
Fabio M. Simoes de Souza et al.
SCIENTIFIC REPORTS (2011)
Perinatal Choline Supplementation Improves Cognitive Functioning and Emotion Regulation in the Ts65Dn Mouse Model of Down Syndrome
Jisook Moon et al.
BEHAVIORAL NEUROSCIENCE (2010)
Lithium Restores Neurogenesis in the Subventricular Zone of the Ts65Dn Mouse, a Model for Down Syndrome
Patrizia Bianchi et al.
BRAIN PATHOLOGY (2010)
Hepatotoxicity of high oral dose (-)-epigallocatechin-3-gallate in mice
Joshua D. Lambert et al.
FOOD AND CHEMICAL TOXICOLOGY (2010)
Memantine Normalizes Several Phenotypic Features in the Ts65Dn Mouse Model of Down Syndrome
Noemi Rueda et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome
Patrizia Bianchi et al.
JOURNAL OF NEUROSCIENCE (2010)
Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome
Lina Chakrabarti et al.
NATURE NEUROSCIENCE (2010)
The Basics of Brain Development
Joan Stiles et al.
NEUROPSYCHOLOGY REVIEW (2010)
Lowering β-Amyloid Levels Rescues Learning and Memory in a Down Syndrome Mouse Model
William J. Netzer et al.
PLOS ONE (2010)
Fetal Exposure to Antidepressants and Normal Milestone Development at 6 and 19 Months of Age
Lars Henning Pedersen et al.
PEDIATRICS (2010)
Prenatal NAP plus SAL prevents developmental delay in a mouse model of Down syndrome through effects on N-methyl-D-aspartic acid and γ-aminobutyric acid receptors
Joy Vink et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2009)
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model
Jason Lockrow et al.
EXPERIMENTAL NEUROLOGY (2009)
Green Tea Polyphenols Rescue of Brain Defects Induced by Overexpression of DYRK1A
Faycal Guedj et al.
PLOS ONE (2009)
Restoration of Norepinephrine-Modulated Contextual Memory in a Mouse Model of Down Syndrome
A. Salehi et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Effects of chronic administration of SGS-111 during adulthood and during the pre- and post-natal periods on the cognitive deficits of Ts65Dn mice, a model of Down syndrome
Noemi Rueda et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
NAP and D-SAL: neuroprotection against the β amyloid peptide (1-42)
Illana Gozes et al.
BMC NEUROSCIENCE (2008)
Mental retardation and associated neurological dysfunctions in Down syndrome: A consequence of dysregulation in critical chromosome 21 genes and associated molecular pathways
Mohammed Rachidi et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2008)
Roles of continuous neurogenesis in the structural and functional integrity of the adult forebrain
Itaru Imayoshi et al.
NATURE NEUROSCIENCE (2008)
Age-related changes in memory and in acetylcholine functions in the hippocampus in the Ts65Dn mouse, a model of Down syndrome
Qing Chang et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
Chronic pentylenetetrazole but not donepezil treatment rescues spatial cognition in Ts65Dn mice, a model for Down syndrome
N. Rueda et al.
NEUROSCIENCE LETTERS (2008)
Incidence of major malformations in infants following antidepressant exposure in pregnancy: Results of a large cohort study
Adrienne Einarson et al.
NEUROTOXICOLOGY AND TERATOLOGY (2008)
Prevention of Developmental Delays in a Down Syndrome Mouse Model
Laura Toso et al.
OBSTETRICS AND GYNECOLOGY (2008)
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test
Alberto C. S. Costa et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Promotion of neuronal plasticity by (-)-epigallocatechin-3-gallate
Wen Xie et al.
NEUROCHEMICAL RESEARCH (2008)
Neurogenesis impairment and increased cell death reduce total neuron number in the hippocampal region of fetuses with Down syndrome
Sandra Guidi et al.
BRAIN PATHOLOGY (2008)
Cerebellum morphogenesis: the foliation pattern is orchestrated by multi-cellular anchoring centers
Anamaria Sudarov et al.
NEURAL DEVELOPMENT (2007)
Defects in embryonic Neurogenesis and initial synapse formation in the Forebrain of the Ts65Dn mouse model of down syndrome
Lina Chakrabarti et al.
JOURNAL OF NEUROSCIENCE (2007)
Early oxidative stress in amniotic fluid of pregnancies with Down syndrome
S. Perrone et al.
CLINICAL BIOCHEMISTRY (2007)
Pharmacotherapy for cognitive impairment in a mouse model of Down syndrome
Fabian Fernandez et al.
NATURE NEUROSCIENCE (2007)
Cell cycle alteration and decreased cell proliferation in the hippocampal dentate gyrus and in the neocortical germinal matrix of fetuses with down syndrome and in Ts65Dn mice
Andrea Contestabile et al.
HIPPOCAMPUS (2007)
Fluoxetine rescues deficient neurogenesis in hippocampus of the Ts65Dn mouse model for Down syndrome
Sarah Clark et al.
EXPERIMENTAL NEUROLOGY (2006)
Safety studies on epigallocatechin gallate (EGCG) preparations. Part 3: Teratogenicity and reproductive toxicity studies in rats
R. A. Isbrucker et al.
FOOD AND CHEMICAL TOXICOLOGY (2006)
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn
CD Chambers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Defective cerebellar response to mitogenic Hedgehog signaling in Down's syndrome mice
RJ Roper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Deficits in hippocampal CA1 LTP induced by TBS but not HFS in the Ts65Dn mouse: A model of Down syndrome
ACS Costa et al.
NEUROSCIENCE LETTERS (2005)
Neonatal signs after late in utero exposure to serotonin reuptake inhibitors - Literature review and implications for clinical applications
EL Moses-Kolko et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism
E Hollander et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Hippocampal long-term potentiation suppressed by increased inhibition in the Ts65Dn mouse, a genetic model of Down syndrome
AM Kleschevnikov et al.
JOURNAL OF NEUROSCIENCE (2004)
Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome
PV Belichenko et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Minocycline prevents cholinergic loss in a mouse model of Down's syndrome
CL Hunter et al.
ANNALS OF NEUROLOGY (2004)
On dendrties in Down syndrome and DS murine models:: a spiny way to learn
R Benavides-Piccione et al.
PROGRESS IN NEUROBIOLOGY (2004)
Development and developmental disorders of the human cerebellum
HJ ten Donkelaar et al.
JOURNAL OF NEUROLOGY (2003)
Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome
AC Granholm et al.
HIPPOCAMPUS (2003)
The effects of piracetam on cognitive performance in a mouse model of Down's syndrome
TH Moran et al.
PHYSIOLOGY & BEHAVIOR (2002)
Estrogen restores cognition and cholinergic phenotype in an animal model of Down syndrome
ACE Granholm et al.
PHYSIOLOGY & BEHAVIOR (2002)
Serotonin and brain development: Role in human developmental diseases
PM Whitaker-Azmitia
BRAIN RESEARCH BULLETIN (2001)
Cell formation in the cortical layers of the developing human cerebellum
H Abrahám et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2001)
Cell formation in the human hippocampal formation from mid-gestation to the late postnatal period
L Seress et al.
NEUROSCIENCE (2001)
Critical periods of vulnerability for the developing nervous system: Evidence from humans and animal models
D Rice et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2000)
分享论文
